Opioid modulation of LH secretion during the oestrous cycle of heifers.
Injections of an opioid agonist (bremazocine) and/or an antagonist (quadazocine) were given to heifers during the luteal or follicular phase of the oestrous cycle. Quadazocine was injected (210 mg/injection) three times at 2-h intervals, and bremazocine was injected (0.45 mg/injection) every 15 min for 6 h. Blood samples were taken every 15 min beginning 6 h before treatments started and continued for 18 h. LH secretion patterns were not affected by quadazocine in the luteal-phase heifers, but quadazocine and bremazocine had marked effects during the follicular phase. Quadazocine increased LH secretion by increasing peak height but not peak frequency. Bremazocine decreased LH secretion through both peak height and frequency. This decrease was of greater magnitude than the increase due to quadazocine. When quadazocine and bremazocine were given together, these effects were cancelled and none of the effects carried over into the bleeding period after treatments stopped. No apparent interruption of follicular maturation was detected since all follicular-phase heifers were detected in oestrus at normal intervals. We conclude that heifers in this experiment did not have an opioid-mediated mechanism for progesterone suppression of LH but that an opioid mechanism for modulating LH does exist during the follicular phase.
D000818:Animals; D001392:Azocines / Q000494:pharmacology*; D001575:Benzomorphans / Q000494:pharmacology*; D002417:Cattle / Q000502:physiology*; D004971:Estrus; D005260:Female; D005498:Follicular Phase; D007986:Luteinizing Hormone / Q000378:metabolism*; D009019:Morphinans / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D012636:Secretory Rate / Q000187:drug effects
D001392:Azocines; D001575:Benzomorphans; D009019:Morphinans; D009292:Narcotic Antagonists; D007986:Luteinizing Hormone; C027248:bremazocine; C035969:quadazocine